Indivior (INDV)

Sector: Pharma and Biotech     Index: FTSE 250
0.19%
0.60p
321.00p
17:20 26/05/17
321.00p
17:20 26/05/17
DAILY VARIATION
0.19%
0.60p
VOLUME
1,804,860
REAL TIME BATS
320.40p
17:36 26/05/17
0.03%
0.10p
DATA
52 Week High
369.60p
52 Week Low
170.20p
Shares Issued
720.78m
Market Cap
£2,313.70m
RiskGrade
111
Beta
0.58
MENU

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 14.1% 29.9%
ROCE 75.6%
Latest F'cast
P/E 11.7 13.4
PEG 4.0 -2.3
Pr/Revenue 2.8 2.7
Pr/Book -10.0
Latest F'cast
Revenue 4.3% 41.2%
PBT -65.6% n/a
EPS 2.9% 82.2%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 1,115.00 561.00 58.00¢ 4.0 0.0 n/a n/a 0.0%
2015-12-31 1,014.00 285.00 34.00¢ 8.1 -0.2 -41% 12.70¢ 4.6%
2016-12-31 1,058.00 98.00 35.00¢ 10.4 3.5 3% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 855.54 255.46 25.45p 13.4 -2.5 -5% 0.00p 0.0%
2018-12-31 876.23 261.31 26.65p 12.9 2.7 5% 0.00p 0.0%

Regulatory News

slide to see more

Newspaper Links

No results found